Omega-3 fatty acids and dyslipidemic agent for reduction of apo-B levels

Details for Australian Patent Application No. 2007307007 (hide)

Owner Reliant Pharmaceuticals, Inc.

Inventors Doyle Jr., Ralph T.; Kling, Douglas; Shalwitz, Robert A.; Rongen, Roelof M. L.

Agent Davies Collison Cave

Pub. Number AU-A-2007307007

PCT Pub. Number WO2008/045465

Priority 60/850,280 10.10.06 US

Filing date 10 October 2007

Wipo publication date 17 April 2008

International Classifications

A61K 31/20 (2006.01)

Event Publications

7 May 2009 PCT application entered the National Phase

  PCT publication WO2008/045465 Priority application(s): WO2008/045465

14 April 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007307013-Method and apparatus for sending feedback for a downlink shared service transmitted to a plurality of wireless transmit/receive units

2007306970-Garment